Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 24Thoracic 17Gynecologic 6Tumor-Agnostic 5Gastrointestinal 3Genitourinary 2Sarcoma 1Other solid neoplasm 1Endocrine 1Dermatologic 1

Conditions

Carcinoma, Neuroendocrine 12Adrenocortical Carcinoma 9Neuroendocrine Tumors 5Small Cell Lung Carcinoma 4Thyroid Carcinoma, Anaplastic 3Peritoneal Neoplasms 3Gastrointestinal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Somatostatinoma 2Sarcoma 2Neoplasms 2Head and Neck Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Small Cell 2Wilms Tumor 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Rhabdomyosarcoma 1Retroperitoneal Neoplasms 1Pheochromocytoma 1Ovarian Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroendocrine Neoplasms 1Neuroblastoma 1Mesothelioma, Malignant 1Medulloblastoma 1Lung Neoplasms 1Liver Neoplasms 1

Interventions

Everolimus 3Sunitinib 2Octreotide 2repotrectinib 1pralsetinib 1pasireotide 1lutetium Lu 177 dotatate 1epothilone B 1cixutumumab 1belinostat 1azaspirane 1avelumab 1Radiotherapy 1Lutetium-177 1Etoposide 1Doxorubicin 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Cisplatin × Endocrine × Clear all
NCT00926640 2018-10-19

A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
28 enrolled
EndocrineThoracic

Carcinoma, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡